Article
Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China.
Tuberculosis (Edinburgh, Scotland) - 1 May 2016
Xu Peng, Wu Jie, Yang Chongguang, Luo Tao, Shen Xin, Zhang Yangyi, Nsofor Chijioke A, Zhu Guofeng, Gicquel Brigitte, Gao Qian
Abstract excerpt
Pyrazinamide (PZA) is an important first-line anti-tuberculosis drug, however, there are relatively few available data on PZA resistant (PZA-R) rate in China. From June 2009 to June 2012, we selected 493 isolates from five field settings in China to investigate PZA-R by pncA gene sequencing. The result showed that PZA-R rate was 1.0% (2/196) among pan-susceptible isolates, 3.1% (4/130) among isoniazid (INH)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
